pBABE-puro TPR-Met Citations (6)
Originally described in: The melanocyte differentiation program predisposes to metastasis after neoplastic transformation.Gupta PB, Kuperwasser C, Brunet JP, Ramaswamy S, Kuo WL, Gray JW, Naber SP, Weinberg RA Nat Genet. 2005 Oct . 37(10):1047-54. PubMed Journal
Articles Citing pBABE-puro TPR-Met
Articles |
---|
6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met. Chan B, VanderLaan PA, Sukhatme VP. Biochem Biophys Res Commun. 2013 Sep 20;439(2):247-51. doi: 10.1016/j.bbrc.2013.08.048. Epub 2013 Aug 22. PubMed |
Signaling mechanisms that suppress the cytostatic actions of rapamycin. Jahn SC, Law ME, Corsino PE, Davis BJ, Harrison JK, Law BK. PLoS One. 2014 Jun 13;9(6):e99927. doi: 10.1371/journal.pone.0099927. eCollection 2014. PubMed |
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer. Bahcall M, Sim T, Paweletz CP, Patel JD, Alden RS, Kuang Y, Sacher AG, Kim ND, Lydon CA, Awad MM, Jaklitsch MT, Sholl LM, Janne PA, Oxnard GR. Cancer Discov. 2016 Dec;6(12):1334-1341. Epub 2016 Sep 30. PubMed |
Sensitivity and Resistance of MET Exon 14 Mutations in Lung Cancer to Eight MET Tyrosine Kinase Inhibitors In Vitro. Fujino T, Kobayashi Y, Suda K, Koga T, Nishino M, Ohara S, Chiba M, Shimoji M, Tomizawa K, Takemoto T, Mitsudomi T. J Thorac Oncol. 2019 Jul 3. pii: S1556-0864(19)30551-9. doi: 10.1016/j.jtho.2019.06.023. PubMed |
MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells. Kitowska K, Gorska-Arcisz M, Antoun D, Zarczynska I, Czaplinska D, Szczepaniak A, Skladanowski AC, Wieczorek M, Stanczak A, Skupinska M, Sadej R. Front Oncol. 2021 Apr 7;11:633410. doi: 10.3389/fonc.2021.633410. eCollection 2021. PubMed |
A slow-cycling/quiescent cells subpopulation is involved in glioma invasiveness. Antonica F, Santomaso L, Pernici D, Petrucci L, Aiello G, Cutarelli A, Conti L, Romanel A, Miele E, Tebaldi T, Tiberi L. Nat Commun. 2022 Aug 15;13(1):4767. doi: 10.1038/s41467-022-32448-0. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.